BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21264540)

  • 1. Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer.
    Tao K; Wu C; Wu K; Li W; Han G; Shuai X; Wang G
    Med Oncol; 2012 Mar; 29(1):107-12. PubMed ID: 21264540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma.
    Lo KW; Tsang YS; Kwong J; To KF; Teo PM; Huang DP
    Int J Cancer; 2002 Apr; 98(5):651-5. PubMed ID: 11920632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
    Ling Y; Shi X; Wang Y; Ling X; Li Q
    Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer.
    Chen C; Wang L; Liao Q; Huang Y; Ye H; Chen F; Xu L; Ye M; Duan S
    Diagn Pathol; 2013 Dec; 8():199. PubMed ID: 24326135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
    Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
    Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation and expression of TIMP3 gene in gastric cancer.
    Guan Z; Zhang J; Song S; Dai D
    Diagn Pathol; 2013 Jul; 8():110. PubMed ID: 23819566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer.
    Zhang H; Song Y; Xia P; Cheng Y; Guo Q; Diao D; Wang W; Wu X; Liu D; Dang C
    Med Oncol; 2014 Feb; 31(2):830. PubMed ID: 24381142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
    Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
    Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
    Hsu LS; Lee HC; Chau GY; Yin PH; Chi CW; Lui WY
    Oncol Rep; 2006 Feb; 15(2):507-11. PubMed ID: 16391877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan.
    Chen SC; Lin CY; Chen YH; Fang HY; Cheng CY; Chang CW; Chen RA; Tai HL; Lee CH; Chou MC; Lin TS; Hsu LS
    Oncol Rep; 2006 Jan; 15(1):167-72. PubMed ID: 16328051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CDH1 Gene Hypermethylation Status in Blood and Serum among Gastric Cancer Patients.
    Li Z; Guo Z
    Pathol Oncol Res; 2020 Apr; 26(2):1057-1062. PubMed ID: 30989488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
    Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
    Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
    Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
    World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer.
    Eftang LL; Klajic J; Kristensen VN; Tost J; Esbensen QY; Blom GP; Bukholm IR; Bukholm G
    BMC Cancer; 2016 Mar; 16():225. PubMed ID: 26984265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells.
    Pao MM; Tsutsumi M; Liang G; Uzvolgyi E; Gonzales FA; Jones PA
    Hum Mol Genet; 2001 Apr; 10(9):903-10. PubMed ID: 11309363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma.
    Wang S; Ding YB; Chen GY; Xia JG; Wu ZY
    World J Gastroenterol; 2004 Jun; 10(12):1815-8. PubMed ID: 15188513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma.
    Jerónimo C; Henrique R; Campos PF; Oliveira J; Caballero OL; Lopes C; Sidransky D
    J Clin Pathol; 2003 Jan; 56(1):52-5. PubMed ID: 12499435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation of esophageal cancer-related gene 4 in gastric cancer tissue and its clinical significance.
    Wang YB; Ba CF
    Hepatogastroenterology; 2012 Sep; 59(118):1696-8. PubMed ID: 22626786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.